Literature DB >> 3689032

Consumption of chloroquine phosphate provided for treatment of malaria by volunteer village health workers in Saradidi, Kenya.

H C Spencer1, D C Kaseje, J M Roberts, A Y Huong.   

Abstract

A community-based malaria control programme in Saradidi, Kenya provided chloroquine treatment for malaria in each village beginning in May 1982. Malaria was holoendemic in Saradidi. Treatment was provided by volunteer community health workers chosen and supported by the village. Consumption of the drug and characteristics of persons treated were recorded. Between 1 September 1982 to 31 August 1983, 40,649 treatments with chloroquine were given to village residents. The treatment rate per person in the mid-year population was 1.24. However, at least 41.8% of the mid-year population of 32,650 did not receive a single treatment. Multiple treatments were given to 50.5% of persons treated at least once and 13.4% of 13,879 persons treated at least once received five or more treatments during the year. Consumption patterns were not random: they were higher in females, in persons above 30 years of age and in the area with greater community organization and community participation. There is need to ascertain the reasons why so large a proportion of the population never received a single treatment in this highly malarious area and why adults who should not have had a high frequency of clinical malaria were treated so often. Nonetheless, the results demonstrate that volunteer community health workers can effectively provide treatment for malaria.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3689032     DOI: 10.1080/00034983.1987.11812197

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  6 in total

Review 1.  Therapy of falciparum malaria in sub-saharan Africa: from molecule to policy.

Authors:  Peter Winstanley; Stephen Ward; Robert Snow; Alasdair Breckenridge
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

Review 2.  The changing limits and incidence of malaria in Africa: 1939-2009.

Authors:  Robert W Snow; Punam Amratia; Caroline W Kabaria; Abdisalan M Noor; Kevin Marsh
Journal:  Adv Parasitol       Date:  2012       Impact factor: 3.870

3.  Reconciling national treatment policies and drug regulation in Kenya.

Authors:  Abdinasir A Amin; Tom Walley; Gilbert O Kokwaro; Peter A Winstanley; Robert W Snow
Journal:  Health Policy Plan       Date:  2007-01-15       Impact factor: 3.344

Review 4.  Antimalarial drug quality in Africa.

Authors:  A A Amin; G O Kokwaro
Journal:  J Clin Pharm Ther       Date:  2007-10       Impact factor: 2.512

5.  Knowledge, attitudes and practices relevant to malaria control in remote island populations of manus, papua new Guinea.

Authors:  Yuji Ataka; Tsukasa Inaoka; Ryutaro Ohtsuka
Journal:  Trop Med Health       Date:  2011-12-01

6.  Impact of community-based presumptive chloroquine treatment of fever cases on malaria morbidity and mortality in a tribal area in Orissa State, India.

Authors:  Lalit K Das; Purushothaman Jambulingam; Candasamy Sadanandane
Journal:  Malar J       Date:  2008-05-05       Impact factor: 2.979

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.